We examined the risk of thrombotic and major bleeding events in patients undergoing total
hip and knee replacement (THR and TKR) treated with thromboprophylaxis, using …

Patients undergoing total hip and knee arthroplasty are at high risk for venous
thromboembolism (VTE) with an incidence of approximately 0.6–1.5%. Given the high …

This study reviewed the effectiveness of a trimodality deep venous thrombosis (DVT)
prophylactic regimen after primary and revision total hip arthroplasty. Seven hundred five …

Background A symptomatic pulmonary embolism (PE) after total joint arthroplasty has been
described as a “never event.” Despite potent anticoagulants and improvements in patient …

The following is a summary of the recommendations of the AAOS'clinical practice guideline,
Preventing Venous Thromboembolic Disease in Patients Undergoing Elective Hip and Knee …

Background The prevalence of asymptomatic deep vein thrombosis diagnosed by
venography after hip or knee replacement remains high despite 7 to 10 days of …

Objective.—While several methods of prophylaxis have been shown to reduce the risk of
venous thromboembolism following total hip replacement, the safest and most effective …

Venous thromboembolic disease (VTE) remains the most common and potentially fatal
complication following total knee replacement (TKR). Its incidence has been reported in …

In the 1960s, the modern era of joint arthroplasty was launched following the first successful
implantation of a long-lasting hip endoprosthesis. 1 More than half a century later, in the …

We compared thromboembolic events, major haemorrhage and death after knee
replacement in patients receiving either aspirin or low-molecular-weight heparin (LMWH) …